forecast

Early Modality Lead Compounds Advantage

Moderna's head start in RNA drugs gives it an advantage in pursuing the low-hanging fruit of this modality, though many competitors will follow.

forecastpending

Speaker

Jason Kelly

Evidence Quote

“they're ahead of other people and pursuing all the other low-hanging fruit for that.”

Source

Moderna: The Software of Life— Business Breakdowns
Created: 11/15/2026, 7:57:10 PM

Your notes

Loading notes...